Paul M. Silva, SVP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 859 shares at $247.18 ($214K) on 2020-04-13, disclosed to the SEC on 2020-04-15.
Scheduled sale ($214k) by SVP & Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $244.09 | 50 | $12K | 5.7% |
| 2 | $245.62 | 150 | $37K | 17.2% |
| 3 | $247.18 | 150 | $37K | 17.4% |
| 4 | $248.96 | 150 | $37K | 17.5% |
| 5 | $250.29 | 193 | $48K | 22.6% |
| 6 | $252.26 | 166 |
| $42K |
| 19.6% |
| Total | $248.72 avg | 859 | $214K | 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |